Silihan lan utang jangka dawa perusahaan: Avenue Therapeutics, Inc (ATXI)

Avenue Therapeutics (ATXI) attracts leading neurobiologists through R&D flexibility and stock option programs. This daily price chart complements data on long-term debt, which stands at 0.00. The business focuses on patenting unique injections for clinics, staying ahead of producers of low-cost generics. Meanwhile, the company relies on strict monitoring of drug transportation to ensure timely delivery to hospitals.

Long-term debt measures the total volume of obligations with a maturity exceeding twelve months. By analyzing the current level of long-term debt, an investor assesses the sustainability of the credit load and financial leverage. This metric aggregates all long-term loans, determining the business's dependence on external capital. For Avenue Therapeutics (ATXI), this is an indicator of the ability to fund costly clinical trials of drugs. Such investments in medical alliances require stable long-term lending.